Tiba Biotech LLC
Tiba Biotech is a preclinical stage biopharmaceutical company developing next-generation RNA vaccines and therapeutics based on a novel dendrimer nanoparticle delivery platform. Their mission is to accelerate science and improve human health beyond borders by creating safer, more effective vaccines and therapeutics with relaxed cold-chain requirements and superior safety profiles. They focus on rapid response to infectious diseases, oncology, gene editing, and other therapeutic applications, leveraging continuous innovation in RNA delivery technology and strategic partnerships with government agencies and research institutions.
Industries
Nr. of Employees
small (1-50)
Products
RNA nanoparticle delivery platform (dendrimer-based)
A dendrimer-derived biodegradable nanoparticle delivery platform for nucleic acid payloads intended for vaccines and therapeutics, designed to enable large payloads with reduced carrier-associated immunogenicity and relaxed cold-chain needs.
RNA nanoparticle delivery platform (dendrimer-based)
A dendrimer-derived biodegradable nanoparticle delivery platform for nucleic acid payloads intended for vaccines and therapeutics, designed to enable large payloads with reduced carrier-associated immunogenicity and relaxed cold-chain needs.
Services
Collaborative preclinical R&D and platform benchmarking
Partnership-based preclinical research to benchmark nucleic acid delivery platforms and advance vaccine and therapeutic candidates.
Contract development of RNA vaccines and therapeutics
Contract R&D to develop RNA vaccine or therapeutic candidates, including formulation, delivery optimization, and preclinical testing.
Technology transfer and pilot manufacturing support
Support for small-scale manufacture and transfer of RNA vaccine candidates to regional manufacturing sites and pilot facilities.
Collaborative preclinical R&D and platform benchmarking
Partnership-based preclinical research to benchmark nucleic acid delivery platforms and advance vaccine and therapeutic candidates.
Contract development of RNA vaccines and therapeutics
Contract R&D to develop RNA vaccine or therapeutic candidates, including formulation, delivery optimization, and preclinical testing.
Technology transfer and pilot manufacturing support
Support for small-scale manufacture and transfer of RNA vaccine candidates to regional manufacturing sites and pilot facilities.
Expertise Areas
- RNA delivery and nanoparticle engineering
- RNA vaccine R&D (self-amplifying and multi-antigen constructs)
- Therapeutic RNA development (siRNA/RNAi)
- Preclinical program design and animal immunology studies
Key Technologies
- Dendrimer-based nanoparticle delivery
- Biodegradable polymeric carriers
- Self-amplifying RNA constructs
- siRNA / RNAi therapeutics